Kurt Nikander has been working in the field of respiratory drug delivery and inhalation devices since 1976. Between 1976–1982 he worked for Astra Pharmaceuticals Finland, in sales and marketing and between 1982–1986 for Draco Läkemedel, Lund, Sweden (subsidiary of Astra Pharmaceuticals), in product management. He worked for AB Draco, Sweden (subsidiary of Astra Pharmaceuticals, international) 1986–1999 in clinical research and development, and 1999–2001 for Astra and AstraZeneca R&D, Lund, Sweden, in medical communication. He left AstraZeneca in 2001 for Profile Therapeutics Inc., Boston, MA, USA (subsidiary of Profile Therapeutics plc, Bognor Regis, West Sussex, UK) to work in product development and clinical research (nebulizers, spacers). Product development and clinical research was the focus of the work even after the acquisitions 2004 by Respironics Inc., NJ, USA, and 2008 by Royal Dutch Philips at Philips Respironics, NJ, USA (2008-2013). Kurt started the InDevCo AB consulting company in 2013 in Nyköping, Sweden focusing on inhalers and related in vitro and clinical research.